AXTI is a compound-semiconductor substrate maker. Five current analyst targets were reviewed: Craig-Hallum's Richard Shannon at $95, Wedbush at $93, Needham's Charles Shi at $90, B. Riley Securities' Dave Kang at $55, and Northland Securities' Tim Savageaux at $125. The arithmetic mean of these five targets is $91.60, which rounds to the $90 central target.
The dispersion stands out: the low of $55 and high of $125 are more than two-to-one apart. This reflects a genuine split in Street thinking. Bullish analysts, including Needham's upgrade to Buy from Hold in July 2026, emphasize record InP backlog and AI-driven demand for high-speed optical interconnect. The more cautious B. Riley Hold rating at $55 reflects concerns about execution, valuation discipline, and converting backlog into sustained profit. A mean of $90 should be read as the midpoint of very different scenarios.
AXTI shares traded near $52 in late October 2026, having pulled back roughly 63% from an all-time high near $143 reached in May 2026. Reaching $90 from around $52 requires an upside of approximately 73%, which qualifies as a very large move. The path is plausible only through a continuation of the AI optical demand cycle: sustained InP pricing, higher average selling prices, and margin expansion driven by capacity utilization. Yet the stock is priced at roughly 27 times trailing sales, far above the semiconductor peer average.
The bull case rests on AXT's roughly 40% share of the indium phosphide substrate market. A record backlog above $100 million and easing China export-permit headwinds give revenue visibility, while supply constraints in InP have supported pricing. A stronger-than-expected June-quarter report, with revenue of $47.6 million and adjusted EPS of $0.19 versus a $0.07 consensus, triggered a sharp repricing and several target increases. Further evidence of accelerating data-center and AI-infrastructure spending would support the optimistic end of the target range. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The principal obstacles are valuation and execution. At around 27 times sales, the market is already discounting a long runway of exceptional growth; any stumble in sequential revenue growth or margins could compress the multiple sharply. Analysts caution that the current margin surge may partly reflect temporary supply tightness, with contractual caps and easing shortages pointing to potential reversion. China export-permit policy remains a persistent overhang given AXT's production footprint, and customer concentration adds further risk. A return to the cautious low end of the target range would leave the $90 objective far out of reach.
The shares have broken below both the 50-day (near $70) and 200-day (near $63) moving averages. The first meaningful support shelf sits in the roughly $45.85 to $46.27 zone; a daily close below about $46 would open the low-$40s. Reclaiming the 200-day average near $63 would be an early sign of structural repair on the way toward higher levels. Short interest of roughly 17.5% of the float means a strong earnings print could fuel a squeeze, though crowded positioning cuts both ways.
Analyst price targets typically reflect a research horizon of roughly 12 months, though the wide $55-to-$125 range shows how differently analysts weight the same catalysts. The near-term focus is the October 29, 2026 earnings report, where consensus models roughly $66 million in revenue and EPS near the company's $0.30-to-$0.32 guidance. Investors should also watch InP pricing commentary, export-permit developments, sequential revenue growth, gross-margin trajectory, and any analyst target revisions in the days following the report. From what I see, these catalysts will determine whether momentum builds.
The $90 target reflects a rounded average of five analyst targets spanning $55 to $125. It requires a very large gain of roughly 73% from the current price near $52, so it represents a materially more optimistic scenario than today's valuation. A durable InP demand cycle, record backlog, and easing export constraints support the upside case, while a stretched multiple, potential margin reversion, and regulatory uncertainty are the principal obstacles. Analyst disagreement is unusually wide, and whether AXTI can reach $90 hinges on continued exceptional execution and demand. Monitor the October earnings report, InP pricing, margins, and post-earnings analyst revisions for the next signal.
In my own research process, I have found Tickeron's AI Daily Buy/Sell Signals useful for volatile names like this one. The tool applies artificial intelligence to monitor thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market conditions. For a heavily shorted stock, these signals can help identify shifts in momentum and complement fundamental work.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AXTI's RSI Oscillator exited the oversold zone, 26 of 33 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
Following a +4.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where AXTI advanced for three days, in 220 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 79%.
AXTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In 210 of 248 cases where AXTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 85%.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AXTI as a result. In 65 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.
The Moving Average Convergence Divergence Histogram (MACD) for AXTI turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 32 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.
AXTI moved below its 50-day moving average on October 09, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for AXTI crossed bearishly below the 50-day moving average on October 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Tickeron PE Growth Rating for this company is 31 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. AXTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AXTI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock better than average.
The Tickeron SMR rating for this company is 90 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.864) is normal, around the industry mean (6.249). AXTI's P/E Ratio (1736.000) is considerably higher than the industry average of (84.682). AXTI's Projected Growth (PEG Ratio) (0.100) is slightly lower than the industry average of (0.832). Dividend Yield (0.000) settles around the average of (0.008) among similar stocks. P/S Ratio (26.596) is also within normal values, averaging (27.093).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufactures of high-performance compound semiconductor substrates
Industry ElectronicProductionEquipment